文献速递消化道肿瘤放疗胸部肿瘤放疗放疗物理与技术

食管癌放化疗期间重复增强4DCT确定的心脏体积变化

Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer.
PubMed 文献 · Radiat Oncol · 2018-09-18

46例非手术食管癌患者在接受根治性同步放化疗前及每10次分次时行增强4DCT和3DCT扫描,由同一放疗医生勾画心脏。心脏体积在第10次和第20次分次时较初始值显著缩小,第30次分次时无显著差异;放疗后收缩压和舒张压降低、心率升高,但未发现与心脏体积变化相关的因素。

要点

  • 46例食管癌患者放疗前及每10次分次行增强4DCT和3DCT,同一医生勾画心脏。
  • 心脏体积第10次分次较初始缩小3.27%–4.52%,第20次分次缩小4.51%–6.05%(均p<0.05),第30次分次无显著差异。
  • 放疗后收缩压降低16.95±16.69 mmHg、舒张压降低7.14±11.64 mmHg,心率升高5.27±6.25次/分(均p<0.05)。

核心结论

  • 心脏体积从治疗早期即显著缩小并持续至治疗中期,3DCT与4DCT所测变化一致。
  • 心脏体积、血压和心率的变化可能是心脏损伤和靶区剂量变化的有价值指标。

研究设计与样本

  • 46例非手术食管癌患者接受根治性同步放化疗,放疗前及每10次分次行增强4DCT和3DCT扫描。
  • 由同一放疗医生在3DCT、4DCT呼气末(EE)和4DCT最大密度投影(MIP)图像上勾画心脏,用SPSS 19.0比较心脏体积等参数。

主要发现

  • 心脏体积第10次分次较初始值缩小:3DCT 3.27%、EE 4.45%、MIP 4.52%(p<0.05)。
  • 心脏体积第20次分次较初始值缩小:3DCT 6.05%、EE 5.64%、MIP 4.51%(p<0.05);第30次分次无显著差异。
  • 放疗后收缩压降低16.95±16.69 mmHg、舒张压降低7.14±11.64 mmHg(均p<0.05),心率升高5.27±6.25次/分(p<0.05)。
  • 所有潜在解释变量均与心脏体积变化无相关性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Concurrent chemoradiotherapy is considered curative intent treatment for patients with non-operative esophageal cancer. Radiation-induced heart damage receives much attention. We performed repeated four-dimensional computed tomography (4DCT) to detect changes in cardiac volume during radiotherapy for esophageal cancer patients, and explored potential factors responsible for those changes. METHODS: Forty-six patients with esophageal cancer underwent enhanced 4DCT and three-dimensional (3D) CT scans before radiotherapy and every 10 fractions during treatment. The heart was contoured on 3DCT images, 4DCT end expiratory (EE) images and 4DCT maximum intensity projection (MIP) images by the same radiation oncologist. Heart volumes and other relative parameters were compared by the SPSS software package, version 19.0. RESULTS: Compared with its initial value, heart volume was smaller at the 10th fraction (reduction = 3.27%, 4.45% and 4.52% on 3DCT, EE and MIP images, respectively, p < 0.05) and the 20th fraction (reduction = 6.05%, 5.64% and 4.51% on 3DCT, EE and MIP images, respectively, p < 0.05), but not at the 30th fraction. Systolic and diastolic blood pressures were reduced (by 16.95 ± 16.69 mmHg and 7.14 ± 11.64 mmHg, respectively, both p < 0.05) and the heart rate was elevated by 5.27 ± 6.25 beats/min (p < 0.05) after radiotherapy. None of the potential explanatory variables correlated with heart volume changes. CONCLUSIONS: Cardiac volume reduced significantly from an early treatment stage and maintained the reduction until the middle stage. The heart volume changes observed on 3DCT and 4DCT were consistent during radiotherapy. The changes in heart volume, blood pressure and heart rate may be valuable indicators of cardiac impairment and target dose changes.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wang X, Wang JZ, Li JB, et al. Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer. Radiat Oncol. 2018. PMID: 30227865. doi:10.1186/s13014-018-1121-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。